Pure red cell aplasia caused by D-penicillamine treatment of rheumatoid arthritis.
AUTOR(ES)
Tishler, M
RESUMO
A 40 year old woman with rheumatoid arthritis developed pure red cell aplasia after treatment with D-penicillamine 500 mg/day. D-Penicillamine was stopped and short term treatment with steroids resulted in complete recovery of bone marrow.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1004397Documentos Relacionados
- Fatal aplastic anaemia and liver toxicity caused by D-penicillamine treatment of rheumatoid arthritis.
- D-penicillamine withdrawal in rheumatoid arthritis.
- Red cell aplasia following prolonged D-penicillamine therapy.
- Acquired sideroblastic anaemia after aplastic anaemia caused by D-penicillamine therapy for rheumatoid arthritis.
- Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis.
